DZ2700A1 - Indoles 2,3-substitués servant d'agents anti-inflammatoires et analgésiques. - Google Patents

Indoles 2,3-substitués servant d'agents anti-inflammatoires et analgésiques.

Info

Publication number
DZ2700A1
DZ2700A1 DZ990001A DZ990001A DZ2700A1 DZ 2700 A1 DZ2700 A1 DZ 2700A1 DZ 990001 A DZ990001 A DZ 990001A DZ 990001 A DZ990001 A DZ 990001A DZ 2700 A1 DZ2700 A1 DZ 2700A1
Authority
DZ
Algeria
Prior art keywords
inflammatory
serving
analgesic agents
substituted indoles
indoles
Prior art date
Application number
DZ990001A
Other languages
English (en)
French (fr)
Inventor
Kazunari Nakao
Rodney William Stevens
Kiyoshi Kawamura
Chikara Koike
Stephane Caron
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DZ2700A1 publication Critical patent/DZ2700A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DZ990001A 1998-01-05 1999-01-04 Indoles 2,3-substitués servant d'agents anti-inflammatoires et analgésiques. DZ2700A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IB9800003 1998-01-05

Publications (1)

Publication Number Publication Date
DZ2700A1 true DZ2700A1 (fr) 2003-09-01

Family

ID=11004645

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ990001A DZ2700A1 (fr) 1998-01-05 1999-01-04 Indoles 2,3-substitués servant d'agents anti-inflammatoires et analgésiques.

Country Status (39)

Country Link
US (1) US6608070B1 (xx)
EP (1) EP1045833B1 (xx)
JP (1) JP3347136B2 (xx)
KR (1) KR100404054B1 (xx)
CN (1) CN1284064A (xx)
AP (1) AP869A (xx)
AR (1) AR016977A1 (xx)
AT (1) ATE308519T1 (xx)
AU (1) AU748107B2 (xx)
BG (1) BG104643A (xx)
BR (1) BR9813124A (xx)
CA (1) CA2316863A1 (xx)
CO (1) CO4970807A1 (xx)
DE (1) DE69832200T2 (xx)
DZ (1) DZ2700A1 (xx)
EA (1) EA200000614A1 (xx)
ES (1) ES2255190T3 (xx)
GT (1) GT199800205A (xx)
HN (1) HN1997000098A (xx)
HR (1) HRP20000454A2 (xx)
HU (1) HUP0102922A3 (xx)
ID (1) ID24876A (xx)
IL (1) IL136885A0 (xx)
IS (1) IS5532A (xx)
MA (1) MA24736A1 (xx)
NO (1) NO20003451L (xx)
OA (1) OA11441A (xx)
PA (1) PA8466201A1 (xx)
PE (1) PE20000055A1 (xx)
PL (1) PL341696A1 (xx)
SA (1) SA99191299A (xx)
SK (1) SK9912000A3 (xx)
TN (1) TNSN99001A1 (xx)
TR (1) TR200001906T2 (xx)
TW (1) TW436482B (xx)
UY (2) UY25332A1 (xx)
WO (1) WO1999035130A1 (xx)
YU (1) YU41600A (xx)
ZA (1) ZA9911B (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555540B1 (en) * 1999-06-30 2003-04-29 Pfizer Inc Combinations of aldose reductase inhibitors and selective cyclooxygenase-2 inhibitors
MXPA00006605A (es) * 1999-07-02 2004-12-09 Pfizer Compuestos de carbonil-indol biciclicos como agentes antiinflamatorios/analgesicos.
ES2182755T3 (es) * 1999-07-02 2003-03-16 Pfizer Compuestos de tetrazolilalquilindol como agentes antiinflamtorios y analgesicos.
EP1572678A4 (en) * 2002-12-19 2008-05-07 Elan Pharm Inc SUBSTITUTED N-PHENYL SULPHONAMIDES ALSBRADYKININ ANTAGONISTS
US7223785B2 (en) 2003-01-22 2007-05-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
US7098231B2 (en) * 2003-01-22 2006-08-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
PL1534305T3 (pl) 2003-05-07 2007-03-30 Osteologix As Leczenie zaburzeń chrząstek i kości solami strontu rozpuszczalnymi w wodzie
KR100795462B1 (ko) 2006-09-27 2008-01-16 한국생명공학연구원 인돌 유도체, 이의 제조방법 및 이를 유효성분으로함유하는 대사성 질환 예방 및 치료용 약학적 조성물
CN101611016B (zh) 2006-10-17 2012-01-25 斯蒂菲尔实验室公司 他拉罗唑代谢物
US20120022121A1 (en) * 2007-11-29 2012-01-26 Dalton James T Indoles, derivatives and analogs thereof and uses therefor
EP2560956B1 (en) * 2010-04-19 2016-10-26 Octeta Therapeutics, LLC Novel synthesis for thiazolidinedione compounds
WO2012006474A2 (en) 2010-07-07 2012-01-12 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
EP2590656B1 (en) 2010-07-07 2017-11-15 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
WO2012006473A1 (en) * 2010-07-07 2012-01-12 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
JP5827328B2 (ja) * 2010-07-07 2015-12-02 アーデリクス,インコーポレーテッド リン酸輸送を阻害する化合物及び方法
AU2011289627B2 (en) 2010-08-10 2015-01-15 Metabolic Solutions Development Company, Llc Synthesis for thiazolidinedione compounds
NZ606574A (en) 2010-08-10 2015-02-27 Metabolic Solutions Dev Co Llc Novel synthesis for thiazolidinedione compounds
US10266490B2 (en) * 2012-03-16 2019-04-23 Georgetown University Radioprotector compounds
US9808443B1 (en) 2016-11-28 2017-11-07 King Saud University Cyclooxygenase inhibitors
CN111004121A (zh) * 2019-12-09 2020-04-14 南京杰运医药科技有限公司 一种4-烷氧基乙酰乙酸酯类化合物的制备方法
CN112409281B (zh) * 2020-08-20 2022-11-18 上海大学 (e)-3-(3-氯-2-氟-6-(1h-四氮唑-1-基)苯基)丙烯酸的合成方法
CA3209491A1 (en) 2021-03-15 2022-09-22 Saul Yedgar Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5604253A (en) * 1995-05-22 1997-02-18 Merck Frosst Canada, Inc. N-benzylindol-3-yl propanoic acid derivatives as cyclooxygenase inhibitors
US5510368A (en) * 1995-05-22 1996-04-23 Merck Frosst Canada, Inc. N-benzyl-3-indoleacetic acids as antiinflammatory drugs
CO5190664A1 (es) * 1999-06-30 2002-08-29 Pfizer Prod Inc Terapia de combinacion para el tratamiento de migrana administracion de un receptor 5ht, cafeina y un inhibidor de ciclooxigenasa-2

Also Published As

Publication number Publication date
CO4970807A1 (es) 2000-11-07
SK9912000A3 (en) 2001-11-06
JP3347136B2 (ja) 2002-11-20
PA8466201A1 (es) 2000-09-29
EP1045833A1 (en) 2000-10-25
HRP20000454A2 (en) 2001-04-30
MA24736A1 (fr) 1999-10-01
UY25590A1 (es) 1999-09-27
AU1500599A (en) 1999-07-26
EP1045833B1 (en) 2005-11-02
AR016977A1 (es) 2001-08-01
TR200001906T2 (tr) 2001-01-22
NO20003451L (no) 2000-09-01
NO20003451D0 (no) 2000-07-04
TNSN99001A1 (fr) 2005-11-10
WO1999035130A1 (en) 1999-07-15
DE69832200T2 (de) 2006-04-20
HUP0102922A2 (hu) 2001-12-28
TW436482B (en) 2001-05-28
AP9801423A0 (en) 1998-12-31
AU748107B2 (en) 2002-05-30
HN1997000098A (es) 1998-12-28
US6608070B1 (en) 2003-08-19
IS5532A (is) 2000-06-13
CN1284064A (zh) 2001-02-14
BG104643A (bg) 2001-02-28
AP869A (en) 2000-09-04
KR100404054B1 (ko) 2003-11-01
GT199800205A (es) 2000-06-21
ATE308519T1 (de) 2005-11-15
ZA9911B (en) 2000-07-04
CA2316863A1 (en) 1999-07-15
DE69832200D1 (de) 2005-12-08
YU41600A (sh) 2003-08-29
IL136885A0 (en) 2001-06-14
KR20010033859A (ko) 2001-04-25
HUP0102922A3 (en) 2003-06-30
EA200000614A1 (ru) 2001-02-26
OA11441A (en) 2004-04-27
UY25332A1 (es) 2001-01-31
JP2002500217A (ja) 2002-01-08
SA99191299A (ar) 2005-12-03
BR9813124A (pt) 2000-10-10
PE20000055A1 (es) 2000-02-08
PL341696A1 (en) 2001-04-23
ES2255190T3 (es) 2006-06-16
ID24876A (id) 2000-08-31

Similar Documents

Publication Publication Date Title
DZ2700A1 (fr) Indoles 2,3-substitués servant d'agents anti-inflammatoires et analgésiques.
MA26831A1 (fr) Derives de benzodiazepine."
ATE240327T1 (de) 1,2-annelierte chinolinderivate
BR9710372B1 (pt) composto, e, composiÇço farmacÊutica.
ATE435861T1 (de) 12,13-cyclopropan-epothilonderivate
IS4963A (is) Setnar 6,5-heteró-bísýklískar afleiður
DE69928945D1 (de) 4,4-biarylpiperidinederivate mit opioid-receptor-wirkung
MA26848A1 (fr) Derives d'heterocyclo-alkylsufonylpyrazole nouveaux servant d'agents anti-inflammatoires/analgesiques.
IT1291709B1 (it) Analoghi di buprenorfina aventi proprieta' analgesiche.
TR199800988A3 (tr) 5' Deoksi-Sitidin türevleri.
HK1036974A1 (en) Indole derivatives and medicinal compositions containing the same.
IT1304008B1 (it) Dispositivo per l'eliminazione di ratti e simili.
IT1302243B1 (it) Sintesi dell'1,1,1,3,3-pentafluoropropano.
NO20003825L (no) 1,3,4 - oxadiazolonderivater
DE60025958D1 (de) 14,15-beta-methylen substituierte androgene
TR199700219A3 (tr) 1,25-Dihidroksi-16, 22, 23-Trisdihidro-kolkalsiferol türevleri.
BR9708948A (pt) 1,3 - Benzodioxois substituídos
ES1041880Y (es) Puya de picador.
ID23006A (id) 13-dihidro-3' aziridino antrasiklina
DK1175397T3 (da) 3,3-substituerede indolinderivater
ES1040071Y (es) Base toma-corriente perfeccionada.
IT1304821B1 (it) Contenitore-programmatore per l'assunzione dei farmaci.
ES1042694Y (es) "expositor perfeccionado".
ES1038556Y (es) "nuevo atril".
ES1037970Y (es) "pernito perfeccionado".